-
1
-
-
0035213478
-
-
Systemic administration of NT is followed by a rapid degradation of the peptide by proteases. Moreover, NT shows only poor blood brain barrier permeability. Intravenous injection of NT and its fragments was reported to cause hypotension:
-
E. B. Binder B. Kinkead M. J. Owens C. B. Nemeroff Pharmacol. Rev. 2001 53 453
-
(2001)
Pharmacol. Rev.
, vol.53
, pp. 453
-
-
Binder, E.B.1
Kinkead, B.2
Owens, M.J.3
Nemeroff, C.B.4
-
2
-
-
0015821329
-
-
The antipsychotic effects are assigned to a co-localization of NTR1 and the dopamine receptor subtype D2:
-
R. Carraway S. E. Leeman J. Biol. Chem. 1973 248 6854
-
(1973)
J. Biol. Chem.
, vol.248
, pp. 6854
-
-
Carraway, R.1
Leeman, S.E.2
-
9
-
-
0025823247
-
-
N. R. F. Al-Rhodan E. Richelson J. A. Gilbert D. J. McCormick K. S. Kanba M. A. Pfenning A. Nelson E. W. Larson T. L. Yaksh Brain Res. 1991 557 227
-
(1991)
Brain Res.
, vol.557
, pp. 227
-
-
Al-Rhodan, N.R.F.1
Richelson, E.2
Gilbert, J.A.3
McCormick, D.J.4
Kanba, K.S.5
Pfenning, M.A.6
Nelson, A.7
Larson, E.W.8
Yaksh, T.L.9
-
17
-
-
0028064680
-
-
For studies on the bioactive conformation of NT(8-13), see:
-
D. L. Heyl A. M. Sefler J. X. He T. K. Sawyer D. J. Wustrow H. C. Akunne M. D. Davis T. Pugsley T. G. Heffner A. E. Corbin W. Cody Int. J. Pept. Protein Res. 1994 44 233
-
(1994)
Int. J. Pept. Protein Res.
, vol.44
, pp. 233
-
-
Heyl, D.L.1
Sefler, A.M.2
He, J.X.3
Sawyer, T.K.4
Wustrow, D.J.5
Akunne, H.C.6
Davis, M.D.7
Pugsley, T.8
Heffner, T.G.9
Corbin, A.E.10
Cody, W.11
-
23
-
-
0029004418
-
-
For recent SAR studies, see:
-
D. J. Wustrow M. D. Davis H. C. Akunne A. E. Corbin J. N. Wiley L. D. Wise T. G. Heffner Bioorg. Med. Chem. Lett. 1995 5 997
-
(1995)
Bioorg. Med. Chem. Lett.
, vol.5
, pp. 997
-
-
Wustrow, D.J.1
Davis, M.D.2
Akunne, H.C.3
Corbin, A.E.4
Wiley, J.N.5
Wise, L.D.6
Heffner, T.G.7
-
24
-
-
0029006468
-
-
A. M. Sefler J. X. He T. K. Sawyer K. E. Holub D. O. Omecinsky M. D. Reily V. Thanabal H. C. Akunne W. L. Cody J. Med. Chem. 1995 38 249
-
(1995)
J. Med. Chem.
, vol.38
, pp. 249
-
-
Sefler, A.M.1
He, J.X.2
Sawyer, T.K.3
Holub, K.E.4
Omecinsky, D.O.5
Reily, M.D.6
Thanabal, V.7
Akunne, H.C.8
Cody, W.L.9
-
32
-
-
0027459083
-
-
D. Gully M. Canton R. Boigegrain F. Jeanjean J.-C. Molimard M. Poncelet C. Gueudet M. Heaulme R. Leyris A. Brouard D. Pelaprat C. Labbé- Jullié J. Mazella P. Soubrié J.-P. Mafrand W. Rostène P. Kitabgi G. Le Fur Proc. Natl. Acad. Sci. U. S. A. 1993 90 65
-
(1993)
Proc. Natl. Acad. Sci. U. S. A.
, vol.90
, pp. 65
-
-
Gully, D.1
Canton, M.2
Boigegrain, R.3
Jeanjean, F.4
Molimard, J.-C.5
Poncelet, M.6
Gueudet, C.7
Heaulme, M.8
Leyris, R.9
Brouard, A.10
Pelaprat, D.11
Labbé- Jullié, C.12
Mazella, J.13
Soubrié, P.14
Mafrand, J.-P.15
Rostène, W.16
Kitabgi, P.17
Le Fur, G.18
-
33
-
-
14444284838
-
-
For characterization and function of the third neurotensin receptor (NTS3), see:
-
D. Gully B. Labeeuw R. Boigegrain F. Oury-Donat A. Bachy M. Poncelet R. Steinberg M. F. Suaud-Chagny V. Santucci N. Vita F. Pecceu C. Labbé-Jullié P. Kitabgi P. Soubrié G. Le Fur J. P. Mafrand J. Pharmacol. Exp. Therap. 1997 280 802
-
(1997)
J. Pharmacol. Exp. Therap.
, vol.280
, pp. 802
-
-
Gully, D.1
Labeeuw, B.2
Boigegrain, R.3
Oury-Donat, F.4
Bachy, A.5
Poncelet, M.6
Steinberg, R.7
Suaud-Chagny, M.F.8
Santucci, V.9
Vita, N.10
Pecceu, F.11
Labbé-Jullié, C.12
Kitabgi, P.13
Soubrié, P.14
Le Fur, G.15
Mafrand, J.P.16
-
34
-
-
15644381411
-
-
J. Mazella N. Zsürger V. Navarro J. Chabry M. Kaghad D. Caput P. Ferrara N. Vita D. Gully J.-P. Maffrand J.-P. Vincent J. Biol. Chem. 1998 273 26273
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 26273
-
-
Mazella, J.1
Zsürger, N.2
Navarro, V.3
Chabry, J.4
Kaghad, M.5
Caput, D.6
Ferrara, P.7
Vita, N.8
Gully, D.9
Maffrand, J.-P.10
Vincent, J.-P.11
-
37
-
-
33748755106
-
-
As an example, see:
-
P. R. Dobner Peptides 2006 27 2405
-
(2006)
Peptides
, vol.27
, pp. 2405
-
-
Dobner, P.R.1
-
38
-
-
78651399683
-
-
and references cited therein For novel insights into GPCR-Peptide Interactions, see:
-
D. M. Rosenbaum C. Zhang J. A. Lyons R. Holl D. Aragao D. H. Arlow S. G. F. Rasmussen H.-J. Choi B. T. DeVree R. K. Sunahara P. Seok Chae S. H. Gellman R. O. Dror D. E. Shaw W. I. Weis M. Caffrey P. Gmeiner B. K. Kobilka Nature 2011 469 236
-
(2011)
Nature
, vol.469
, pp. 236
-
-
Rosenbaum, D.M.1
Zhang, C.2
Lyons, J.A.3
Holl, R.4
Aragao, D.5
Arlow, D.H.6
Rasmussen, S.G.F.7
Choi, H.-J.8
Devree, B.T.9
Sunahara, R.K.10
Seok Chae, P.11
Gellman, S.H.12
Dror, R.O.13
Shaw, D.E.14
Weis, W.I.15
Caffrey, M.16
Gmeiner, P.17
Kobilka, B.K.18
-
40
-
-
79955395484
-
-
The native ligands NT and NT(8-13) show highest affinities for NTS1, followed by NTS2 and NTS3:
-
E. Richelson, D. J. McCormick, Y.-P. Pang, and K. S. Phillips, PCT/US2008/062472, WO/2008/137720
-
-
-
Richelson, E.1
McCormick, D.J.2
Pang, Y.-P.3
Phillips, K.S.4
-
42
-
-
0032930831
-
-
I. Dubuc P. Sarret C. Labbé-Jullié J.-M. Botto E. Honoré E. Bourdel J. Martinez J. Costentin J.-P. Vincent P. Kitabgi J. Mazella J. Neurosci. 1999 19 503
-
(1999)
J. Neurosci.
, vol.19
, pp. 503
-
-
Dubuc, I.1
Sarret, P.2
Labbé-Jullié, C.3
Botto, J.-M.4
Honoré, E.5
Bourdel, E.6
Martinez, J.7
Costentin, J.8
Vincent, J.-P.9
Kitabgi, P.10
Mazella, J.11
-
44
-
-
0004269715
-
-
P. Renaud, M. P. Sibi, 1st ed., Wiley-VCH, Weinheim, 62
-
A. Studer, and M. Brossart, in Radicals in Organic Synthesis, ed., P. Renaud, M. P. Sibi, 1st ed., Wiley-VCH, Weinheim, 2001, Vol. 2, 62
-
(2001)
Radicals in Organic Synthesis, Ed.
-
-
Studer, A.1
Brossart, M.2
-
46
-
-
0004125345
-
-
Wiley, Chichester, 167 For review articles on biaryl synthesis via CH-activation, see:
-
J. Fossey, D. Lefort, and J. Sorba, Free Radicals in Organic Chemistry, Wiley, Chichester, 1995, 167
-
(1995)
Free Radicals in Organic Chemistry
-
-
Fossey, J.1
Lefort, D.2
Sorba, J.3
-
52
-
-
26644444613
-
-
A. Griesbeck, J. Mattay, Marcel Dekker, New York, 495
-
R. A. Rossi, in Synthetic Organic Photochemistry, ed., A. Griesbeck, J. Mattay, Marcel Dekker, New York, 2005, Vol. 12, 495
-
(2005)
Synthetic Organic Photochemistry, Ed.
-
-
Rossi, R.A.1
-
54
-
-
79955370164
-
-
L. A. Paquette, R. Bittman, Wiley&Sons, 1
-
R. A. Rossi, A. B. Pierini, and A. N. Santiago, in Organic Reactions, ed., L. A. Paquette, R. Bittman, Wiley&Sons, 1999, 1
-
(1999)
Organic Reactions, Ed.
-
-
Rossi, R.A.1
Pierini, A.B.2
Santiago, A.N.3
-
60
-
-
33746877486
-
-
The improved protocols for the Fmoc-protection and methyl ester hydrolysis are based on procedures reported by
-
M. R. Heinrich O. Blank S. Wölfel Org. Lett. 2006 8 3323
-
(2006)
Org. Lett.
, vol.8
, pp. 3323
-
-
Heinrich, M.R.1
Blank, O.2
Wölfel, S.3
-
61
-
-
0001233245
-
-
Low concentrations of the diazonium ions 6 do not effectively support the chain (see ref. 20) whereas high concentration usually lead to homocoupling (addition of aryl radical 8 to diazonium salt 6):
-
J. G. Adamson M. A. Blaskovich H. Groenevelt G. A. Lajoie J. Org. Chem. 1991 56 3447
-
(1991)
J. Org. Chem.
, vol.56
, pp. 3447
-
-
Adamson, J.G.1
Blaskovich, M.A.2
Groenevelt, H.3
Lajoie, G.A.4
-
63
-
-
2942545129
-
-
For a recent report on the arylation of tyrosines by a Suzuki-Miyaura reaction, see:
-
C. Galli Chem. Rev. 1988 88 765
-
(1988)
Chem. Rev.
, vol.88
, pp. 765
-
-
Galli, C.1
-
65
-
-
33746326836
-
-
The unsuccessful tert-butyl protection of (S)-11b using isobutene was carried out according to a procedure suitable for tyrosines. See ref. 27
-
S. Knör B. Laufer H. Kessler J. Org. Chem. 2006 71 5625
-
(2006)
J. Org. Chem.
, vol.71
, pp. 5625
-
-
Knör, S.1
Laufer, B.2
Kessler, H.3
-
67
-
-
75749153010
-
-
S. Maschauer J. Einsiedel R. Haubner C. Hocke M. Ocker H. Hübner T. Kuwert P. Gmeiner O. Prante Angew. Chem. Int. Ed. 2010 49 976
-
(2010)
Angew. Chem. Int. Ed.
, vol.49
, pp. 976
-
-
Maschauer, S.1
Einsiedel, J.2
Haubner, R.3
Hocke, C.4
Ocker, M.5
Hübner, H.6
Kuwert, T.7
Gmeiner, P.8
Prante, O.9
|